Intraoperative pancreas stump perfusion assessment during pancreaticoduodenectomy: A systematic scoping review

Table 1 Study characteristics of included articles

Ref.	Country of origin	Study design	Study population	Disease process
Strasberg et al[25], 2002	United States	Prospective cohort	Patients undergoing pancreatoduodenectomy with pancreatojejunostomy at a single institution 1996 to 2000	Malignant (n = 107): Pancreatic cancer (n = 48); ampullary cancer (n = 28); NET (n = 6); villous adenoma (n = 6); MCN (n = 6); bile duct cancer (n = 5); duodenal adenocarcinoma (n = 3); serous cystadenoma (n = 3); IPMN (n = 1); GIST (n = 1). Benign (chronic pancreatitis, n = 16)
Subar et al[24], 2015	France	Case report	One patient undergoing laparoscopic pancreatoduodenectomy with pancreatojejunostomy	Malignant (ampullary adenocarcinoma)
Rho et al[23], 2019	Korea	Case report	One patient undergoing laparoscopic pancreatoduodenectomy with pancreatojejunostomy	Malignant (distal cholangiocarcinoma)
Doussot et al[27], 2021	France	Prospective cohort	Consecutive patients undergoing open pancreatoduodenectomy with pancreatojejunostomy at a single institution from January 2020 to November 2020	Malignant (n = 30, periampullary malignancies)
Iguchi et al[26], 2021	Japan	Case report	One patient undergoing open middle segment-preserving pancreatectomy with pancreatojejunostomy	Malignant (pancreatic ductal adenocarcinoma in head of pancreas with IPMN in the tail of pancreas)

NET: Neuro endocrine tumour; MCN: Mucinous cystic neoplasm; IPMN: Intraductal papillary mucinous neoplasm; GIST: Gastrointestinal stromal tumour.